Mathematical Analysis of a Model for Assessing the Impact of Antiretroviral Therapy, Voluntary Testing and Condom Use in Curtailing the Spread of HIV

Differential Equations and Dynamical Systems

Volumn 19, Issue 4, 2011, Pages 283-302

  Podder, C N ^a   Sharomi, O ^a   Gumel, A B ^a   Strawbridge, E ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ARVs; Condoms; HIV; Nucleic acid amplification testing (NAAT); Reproduction number; Stability; Standard testing

Indexed keywords

EID: 84859711962     PISSN: 09713514     EISSN: 09746870     Source Type: Journal    
DOI: 10.1007/s12591-011-0090-6     Document Type: Article

References (44)

1. Alimadad A., Edwards M., Feher B., Gemmrich S., Gumel A. B., Langmore I., Sharomi O., Strawbridge E., Steinberg M., Taylor D., Yurtseven O., Zhang Y.: In: Proceedings of the 10th PIMS Industrial Problem Solving Workshop. Simon Fraser University, Vancouver (2006).
2. Antiretroviral therapy coverage rate in low- and middle-income countries. http://www. aidsportal. org/Article_Details. aspx?ID=3121 (2006). Accessed September 2010.
3. Aubert B., Taljaard D., Lagrade E., Sobngwi-Tambekou J., Sitta R. et al.: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2, e298 (2005).
4. Blower S. M., Dowlatabadi H.: Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int. Stat. Rev. 62, 229-243 (1994).
5. Blower S. M., Aschenbach A. N., Gershengorn H. B., Kahn J. O.: Predicting the unpredictable: transmission of drug-resistant HIV. Nat. Med. 9(7), 1016-1020 (2001).
6. Centers For Disease Control: Morbidity and mortality weekly report. MMWR 55, No. RR-14 (2006).
7. Davis K. R., Weller S. C.: The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam. Plan. Prospect. 31(6), 272-279 (1999).
8. 0 in models for infectious diseases in heterogeneous populations. J. Math. Biol. 28, 503-522 (1990).
9. Dixon S., McDonald S., Roberts J.: The impact of HIV and AIDS on Africa's economic development. BMJ 324, 232-234 (2002).
10. Elbasha E. H., Gumel A. B.: Theoretical assessment of public health impact of imperfect prophylactic HIV-1 vaccines with therapeutic benefits. Bull. Math. Biol. 68, 577-614 (2006).
11. Esteva L., Vargas de León C.: Influence of vertical and mechanical transmission on the dynamics of dengue disease. Math. Biosci. 167, 51-64 (2000).
12. Esteva L., Gumel A. B., Vargas de León C.: Qualitative study of transmission dynamics of drug-resistant malaria. Math. Comput. Model. 50(3-4), 611-630 (2009).
13. Fauci A. S., Pantaleo G., Stanley S., Weissman D.: Immunopathogenic mechanisms of HIV infection. Ann. Intern. Med. 124, 654-663 (1996).
14. Fleck F.: Developing economies shrink as AIDS reduces workforce. BMJ 329, 129 (2004).
15. Gumel A. B., Connell McCluskey C., van den Driessche P.: Mathematical study of a staged-progression HIV model with imperfect vaccine. Bull. Math. Biol. 68(8), 2105-2128 (2006).
16. Hethcote H. W.: The mathematics of infectious diseases. SIAM Rev. 42, 599-653 (2000).
17. Hethcote H. W., Thieme H. R.: Stability of the endemic equilibrium in epidemic models with subpopulations. Math. Biosci. 75, 205-227 (1985).
18. Hyman J. M., Li J., Stanley E. A.: The differential infectivity and staged progression models for the transmission of HIV. Math. Biosci. 208, 227-249 (1999).
19. Jacquez J. A., Koopman J. S., Simon C. P., Longini I. M.: Role of the primary infection in epidemics of HIV infection in gay cohorts. J. Acquir. Immune Defic. Syndr. 7(11), 1169-1184 (1994).
20. Lakshmikantham V., Leela S., Martynyuk A. A.: Stability Analysis of Nonlinear Systems. Marcel Dekker Inc., New York (1989).
21. LaSalle, J. P.: The Stability of Dynamical Systems. Regional Conference Series in Applied Mathematics. SIAM, Philadelphia (1976).
22. Longini I., Clark W., Byers R.: Statistical analysis of the stages of HIV infections using a Markov model. Stat. Med. 8, 831-843 (1989).
23. Lopez A. D., Mathers C. D., Ezzati M., Jamison D. T., Murray C. J. L.: Global Burden of Disease and Risk Factors. A Co-publication of the World Bank and Oxford University Press, Washington, DC/New York (2006).
24. Marks G., Crepaz N., Janssen R. S.: Meta-analysis of high-risk sexual behaviour in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J. Acquir. Immune Defic. Syndr. 39(4), 446-453 (2005).
25. Marks G., Crepaz N., Janssen R. S.: Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 20, 1447-1450 (2006).
26. McCluskey C.: A model of HIV/AIDS with staged progression and amelioration. Math. Biosci. 181, 1-16 (2003).
27. McLeod R. G., Brewster J. F., Gumel A. B., Slonowsky D. A.: Sensitivity and uncertainty analysis for a SARS model with time-varying inputs and outputs. Math. Biosci. Eng. 3, 527-544 (2006).
28. Mellors J., Munoz A., Giorgi J., Margolick J., Tassoni C. et al.: Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126, 946-954 (1997).
29. Mills E. J. et al.: Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta analysis. JAMA 296(6), 679-690 (2006).
30. Perelson A., Nelson P.: Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 41, 3-44 (1999).
31. Pilcher C. D., Fiscus S. A., Nguyen T. Q., Foust E., Wolf L.: Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med. 352(18), 1873-1883 (2005).
32. Podder C. N., Gumel A. B., Bowman C. S., McLeod R. G.: Mathematical study of the impact of quarantine, isolation and vaccination in curtailing an epidemic. J. Biol. Syst. 15(2), 185-202 (2007).
33. Porco T. C., Blower S. M.: Designing HIV vaccination policies subtypes and cross-immunity. Interfaces 28(3), 167-190 (1998).
34. Quinn, T. C., Wawer, M. J., Sewankambo, N., et al. for the Rakai Project Study Group: Viral load and heterosexual transmission of human immunodeficiency virus. N. Engl. J. Med. 342, 921-929 (2000).
35. Rapatski B. L., Suppe F., Yorke J. A.: HIV epidemics driven by late disease stage transmission. J. Acquir. Immune Defic. Syndr. 38(3), 241-253 (2005).
36. Report on the Global AIDS Epidemic: Executive summary/UNAIDS: a UNAIDS 10th anniversary special edition. http://data. unaids. org/pub/GlobalReport/2006/2006_GR-ExecutiveSummary_en. pdf (2006). Accessed November 2009.
37. Simpson, K. N., Biddle, A. C., Leone, P. A., Wolf, L., Williams, D., Kuruc, J., McCoy, S., Miller, W. C., Hightow, L. B., Pilcher, C. D.: Cost effectiveness of screening for acute HIV-infection: the North Carolina STAT program. Private communication to BC CDC (2006).
38. UNAIDS: More than five million people receiving HIV treatment. http://www. unaids. org/en/KnowledgeCentre/Resources/FeatureStories/archive/2010/20100719_Vienna_PR_WHO. asp (2010). Accessed September 2010.
39. United Nations Department of Economic and Social Affairs/Population Division: The impact of AIDS. United Nations. http://www. un. org/esa/population/publications/AIDSimpact/22_EXEC_SUMMARY_English. pdf (2002). Accessed November 2009.
40. U. S. Global Health Policy: The global HIV/AIDS epidemic: fact sheet. http://www. kff. org/hivaids/upload/3030-13. pdf (2009). Accessed 10 November 2009.
41. van den Driessche P., Watmough J.: Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180, 29-48 (2002).
42. Wawer M. et al.: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191, 1403-1409 (2005).
43. WHO: The World Health Report: Changing History. World Health Organization, Geneva (2004).
44. World Bank: Confronting AIDS: Public Priorities in a Global Epidemic. Oxford University Press, New York (1997).